Mechanisms of cytomegalovirus to tumor transmission across the blood brain barrier in glioblastoma

Bibliographic Details
Published in:	Brain and Spine
Main Authors:	H. Krenzlin, L. Schmidt, N. Lemmermann, S. Lawler, F. Ringel, N. Keric
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772529422006415

Similar Items

Cytomegalovirus-induced oncomodulation drives immune escape in glioblastoma
by: Harald Krenzlin, et al.
Published: (2025-07-01)

CMV infection in glioblastoma - Oncomodulation through changes to the glioma immune landscape
by: Harald Krenzlin, et al.
Published: (2023-01-01)

Frailty are associated with increased post-operative morbidity and shortened overall survival in geriatric patients with glioblastoma
by: D. Jankovic, et al.
Published: (2021-01-01)

Regorafenib- A feasible option as third-line therapy of recurrent glioblastoma?
by: Alice Dauth, et al.
Published: (2023-01-01)

Longitudinal analysis of the immune landscape in recurrent glioblastoma – Infiltration of Natural killer cells and TCR clonality as biomarkers of overall survival
by: Harald Krenzlin, et al.
Published: (2023-01-01)

Intermodal comparison of supine magnetic resonance imaging (MRI) and computed tomography (CT) versus functional radiographs to determine dynamic instability in patients with lumbar degenerative spondylolisthesis
by: H. Krenzlin, et al.
Published: (2021-01-01)

Impact of sarcopenia, obesity and bone mineral density on implant failure after spondylodesis in patients with osteoporotic vertebral fractures
by: H. Krenzlin, et al.
Published: (2022-01-01)

Device-assisted strategies for drug delivery across the blood-brain barrier to treat glioblastoma
by: Nassir Mokarram, et al.
Published: (2025-01-01)

Clinical implications of cytomegalovirus in glioblastoma progression and therapy
by: Noe B. Mercado, et al.
Published: (2024-09-01)

Systemic Administration of Argatroban Reduces Secondary Brain Damage in a Mouse Model of Intracerebral Hemorrhage
by: Harald Krenzlin, et al.
Published: (2023-01-01)

Intermodal Detection of Lumbar Instability in Degenerative Spondylolisthesis is Superior to Functional Radiographs
by: Harald Krenzlin, et al.
Published: (2022-06-01)

Feasibility and safety of titanium-enhanced biocompatible calcium-phosphate implants for cranioplasty
by: D.M.A. Wesp, et al.
Published: (2021-01-01)

Titer of antibodies to cytomegalovirus in blood of patients at brain tumors
by: Nikolay Lisianyi, et al.
Published: (2013-09-01)

Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment
by: Qi Cai, et al.
Published: (2023-08-01)

Influence of Blood Components on Neuroinflammation, Blood–Brain Barrier Breakdown, and Functional Damage After Acute Subdural Hematoma in Rats
by: Daniel Jussen, et al.
Published: (2024-11-01)

Influence of Blood Components on Neuroinflammation, Blood?Brain Barrier Breakdown, and Functional Damage After Acute Subdural Hematoma in Rats
by: Daniel Jussen, et al.
Published: (2024-03-01)

Influence of frailty and sarcopenia on long-term neurological outcome in patients with aneurysmatic subarachnoid hemorrhage.
by: Dragan Jankovic, et al.
Published: (2023-01-01)

Involuntary ambulatory triage during the COVID-19 pandemic - A neurosurgical perspective.
by: Harald Krenzlin, et al.
Published: (2020-01-01)

Optical Modulation of the Blood-Brain Barrier for Glioblastoma Treatment
by: Qi Cai, et al.
Published: (2024-01-01)

Single‐cell transcriptomic analysis of glioblastoma reveals pericytes contributing to the blood–brain–tumor barrier and tumor progression
by: Yuzhe Li, et al.
Published: (2024-12-01)

GCN5-targeted dual-modal probe across the blood-brain barrier for borders display in invasive glioblastoma
by: Haiyan Zheng, et al.
Published: (2025-03-01)

Impact of Sarcopenia and Bone Mineral Density on Implant Failure after Dorsal Instrumentation in Patients with Osteoporotic Vertebral Fractures
by: Harald Krenzlin, et al.
Published: (2022-05-01)

Impact of extent of resection in relation to MGMT status on survival in recurrent glioblastoma
by: Dr. Dragan Jankovic, et al.
Published: (2025-01-01)

Material considerations for delivering therapeutics across the blood–brain barrier
by: Ava N. Zoba, et al.
Published: (2025-08-01)

Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro
by: Sabrina Digiovanni, et al.
Published: (2024-11-01)

Nanoparticle Strategies to Improve the Delivery of Anticancer Drugs across the Blood–Brain Barrier to Treat Brain Tumors
by: Wouter J. F. Vanbilloen, et al.
Published: (2023-06-01)

Sphenopalatine Ganglion Stimulation Upregulates Transport of Temozolomide across the Blood-Brain Barrier
by: Thana N. Theofanis, et al.
Published: (2020-09-01)

Chemotherapy in pediatric brain tumor and the challenge of the blood–brain barrier
by: Johid Reza Malik, et al.
Published: (2023-12-01)

Blood-Brain Barrier, Blood-Brain Tumor Barrier, and Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels to Brain Tumors
by: Evgenii Belykh, et al.
Published: (2020-06-01)

Chlorpyrifos Disrupts Acetylcholine Metabolism Across Model Blood-Brain Barrier
by: Dusty R. Miller, et al.
Published: (2021-08-01)

Transport of Amino Acids Across the Blood-Brain Barrier
by: Rosa Zaragozá
Published: (2020-09-01)

PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular Heterogeneity
by: Shiv K. Gupta, et al.
Published: (2019-01-01)

Characteristics of the blood–brain barrier in pediatric brain tumors
by: Qiang Gao, et al.
Published: (2025-08-01)

Role of hyperconnectivity between tumor and healthy brain in glioblastoma patients
by: Dr. Veit Stoecklein, et al.
Published: (2025-01-01)

Cytomegalovirus infection of brain tumors and CMV immunotherapy
by: Mykola I. Lisianyi, et al.
Published: (2022-09-01)

Editorial: The blood-brain barrier in brain tumors: molecular mechanisms and therapeutic strategies
by: Lei Zhang, et al.
Published: (2023-07-01)

Role of cytomegalovirus in glioblastoma development: promoter or culprit?
by: Xiaoxin Wu, et al.
Published: (2025-06-01)

Direct Evidence for Viral Antigen Presentation during Latent Cytomegalovirus Infection
by: Niels A. W. Lemmermann, et al.
Published: (2021-06-01)

Generation of Heterotypic Primary Human Spheroids from Glioblastoma Resections and (Pre-)Clinical Applications
by: Sophia Elisa Wiener, et al.
Published: (2026-06-01)

Ligands for oral delivery of peptides across the blood-brain-barrier
by: Murad Al Gailani, et al.
Published: (2022-04-01)